Table 3: Demographics and risk factors of the patients with HDAVB who underwent permanent pacemaker implantation versus those did not.
Pacemaker (n=2,580) | No pacemaker (n=900) | p-value | |
---|---|---|---|
Age (mean ±standard deviation) | 82 ± 8 | 82 ± 8 | 0.64 |
Male | 52.1% | 47.2% | 0.23 |
Race White | 82.8% | 82.2% | 0.86 |
Hypertension | 80.0% | 76.7% | 0.27 |
Diabetes | 38.8% | 33.3% | 0.19 |
Dyslipidemia | 65.5% | 55.0% | 0.01 |
Current smoking | 2.7% | 2.8% | 0.96 |
Obesity | 16.3% | 9.4% | 0.01 |
Coronary artery disease | 29.7% | 31.7% | 0.58 |
Prior PCI | 18.0% | 15.6% | 0.37 |
Prior CABG | 19.8% | 15.6% | 0.13 |
Prior stroke/TIA | 11.6% | 7.8% | 0.11 |
Anemia | 25.6% | 24.4% | 0.71 |
Renal failure | 40.1% | 37.2% | 0.45 |
Chronic pulmonary disease | 32.8% | 31.7% | 0.78 |
Peripheral vascular disease | 28.9% | 30.0% | 0.74 |
Atrial fibrillation | 38.0% | 42.2% | 0.22 |
In-hospital mortality | 3.1% | 12.2% | <0.001 |
CABG: coronary artery bypass grafting, PCI: percutaneous coronary intervention, TAVI: trans-catheter aortic valve implantation, TIA: transient ischemic attack,